BR

Buripally Ravindhar

Director Director DIN 08352120
DIN 08352120 First appointment Feb 2019 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2019
Shareholding value Locked Premium profile

About Buripally Ravindhar

Buripally Ravindhar has 7 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 08352120
Primary Designation Director
First Appointment 05 Feb 2019
Oldest Company Age 9 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Msb Pharma Private Limited U24239TG2017PTC119079
Director 05 Feb 2019 2017 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Msb Pharma Private Limited
Premium access

Shareholding and investment profile for Buripally Ravindhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Buripally Ravindhar

Buripally Ravindhar has 7 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Buripally Ravindhar is associated with 0 companies as Director.

Buripally Ravindhar has expertise in General Business.

Buripally Ravindhar has 7 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available